Edition:
India

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

4.08USD
15 Dec 2017
Change (% chg)

$0.01 (+0.25%)
Prev Close
$4.07
Open
$4.10
Day's High
$4.10
Day's Low
$3.68
Volume
7,283
Avg. Vol
1,952
52-wk High
$4.13
52-wk Low
$1.92

Chart for

About

Biomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of... (more)
No analyst recommendations are available for .

Overall

Beta: -0.58
Market Cap(Mil.): $24.61
Shares Outstanding(Mil.): 8.52
Dividend: --
Yield (%): --

Financials

BRIEF-Biomerica Enters Into At Market Issuance Sales Agreement With B. Riley FBR

* BIOMERICA INC - ‍ON DEC. 1, 2017, CO ENTERED INTO AN AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY FBR, INC - SEC FILING​

04 Dec 2017

BRIEF-Biomerica extends license agreement with Celtis Pharm

* Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

07 Nov 2017

BRIEF-Biomerica Inc Q1 ‍net sales $1.4 million

* Net sales of $1.4 million for three months ending August 31, 2017, an increase of 2.4%​

17 Oct 2017

BRIEF-Biomerica commences clinical studies for new Gastroenterology H. Pylori test

* Biomerica commences clinical studies for new Gastroenterology H. Pylori test

12 Sep 2017

BRIEF-Biomerica announces point of care product distribution agreement with a multinational pharmaceutical company

* Biomerica announces point of care product distribution agreement with a multinational pharmaceutical company

16 Aug 2017

BRIEF-Biomerica files for stock shelf of up to $45 mln

* Biomerica Inc files for stock shelf of up to $45 million - SEC filing Source text: (http://bit.ly/2sqnkhi) Further company coverage:

01 Jul 2017

Earnings vs. Estimates